Activated protein C resistance is a hemostatic disorder characterized by a reduced anticoagulant response to activated protein C, often due to a mutation in the factor V gene known as Factor V Leiden. This condition increases the risk of venous thromboembolism, making it a significant concern in clinical settings for thrombotic risk assessment and management.